have a poor prognosis because of late clinical manifes-tation and the tumor’s aggressive nature. We used pro-teomic techniques to search for markers of pancreatic carcinoma. Methods: We performed protein profiling of microdis-sected cryostat sections of 9 pancreatic adenocarcinomas and 10 healthy pancreatic tissue samples using Protein-Chip technology (surface-enhanced laser desorption/ ionization). We identified proteins by use of 2-dimen-sional gel electrophoresis, peptide fingerprint mapping, and immunodepletion and used immunohistochemistry for in situ localization of the proteins found. We used ELISA to quantify these proteins in preoperative serum samples from 35 patients with pancreatic cancer and 37 healthy individuals
Pancreatic cancer has one of the lowest survival rates of all cancers, partly due to the difficulty ...
The driving force behind oncoproteomics is to identify protein signatures that are associated with a...
BACKGROUND: Pancreatic cancer (PC) surveillance is currently offered to individuals with a genetic p...
In the United States, mortality rates from pancreatic cancer (PCa) have not changed significantly ov...
AbstractBackgroundCurrently, no suitable biomarkers for the early detection of pancreatic cancer (PC...
In the United States, mortality rates from pancreatic cancer (PCa) have not changed significantly ov...
Pancreatic cancer is a devastating disease with one of the lowest survival rates of all cancers, par...
Pancreatic cancer is a uniformly lethal disease that is difficult to diagnose at early stage and eve...
Novel serological biomarkers to aid in the detection and clinical management of pancreatic cancer pa...
Proteomics is the term used for the large-scale analysis of proteins in biological fluids or cells b...
We performed an integrated analysis of proteomic and transcriptomic datasets to develop potential di...
Pancreatic cancer has one of the lowest survival rates of all cancers, partly due to the difficulty ...
Pancreatic cancer remains the most fatal human tumor type. The aggressive tumor biology coupled with...
ABSTRACT: Pancreatic cancer is a lethal disease where specific early detection biomarkers would be v...
Cellular heterogeneity of solid tumors represents a common problem in mass spectrometry (MS)-based a...
Pancreatic cancer has one of the lowest survival rates of all cancers, partly due to the difficulty ...
The driving force behind oncoproteomics is to identify protein signatures that are associated with a...
BACKGROUND: Pancreatic cancer (PC) surveillance is currently offered to individuals with a genetic p...
In the United States, mortality rates from pancreatic cancer (PCa) have not changed significantly ov...
AbstractBackgroundCurrently, no suitable biomarkers for the early detection of pancreatic cancer (PC...
In the United States, mortality rates from pancreatic cancer (PCa) have not changed significantly ov...
Pancreatic cancer is a devastating disease with one of the lowest survival rates of all cancers, par...
Pancreatic cancer is a uniformly lethal disease that is difficult to diagnose at early stage and eve...
Novel serological biomarkers to aid in the detection and clinical management of pancreatic cancer pa...
Proteomics is the term used for the large-scale analysis of proteins in biological fluids or cells b...
We performed an integrated analysis of proteomic and transcriptomic datasets to develop potential di...
Pancreatic cancer has one of the lowest survival rates of all cancers, partly due to the difficulty ...
Pancreatic cancer remains the most fatal human tumor type. The aggressive tumor biology coupled with...
ABSTRACT: Pancreatic cancer is a lethal disease where specific early detection biomarkers would be v...
Cellular heterogeneity of solid tumors represents a common problem in mass spectrometry (MS)-based a...
Pancreatic cancer has one of the lowest survival rates of all cancers, partly due to the difficulty ...
The driving force behind oncoproteomics is to identify protein signatures that are associated with a...
BACKGROUND: Pancreatic cancer (PC) surveillance is currently offered to individuals with a genetic p...